Conclusion
There are already available scoring systems which take age into account as an important variable along with a large number of other outcome determinants. Thus, if by agism we mean the discrimination against the elderly solely on the grounds of their being old, the APACHE-system is not agist. However, in this respect, scoring systems need refinement, as attempted in the third version of APACHE. Finally, it should be remembered that these scoring systems are not intended to replace but to supplement clinical judgement.
Similar content being viewed by others
References
Nyström P-O, Bax R, Dellinger EP, et al. Proposed definitions for diagnosis, severity scoring, stratification, and outcome for trials on intraabdominal infection. World J Surg 1990; 14: 148–58
Marik P, Kraus P, Sribante J, et al. Hydrocortisone and tumor necrosis factor in severe community-acquired pneumonia: a randomized controlled study. Chest 1993; 104: 389–92
Moran JL, O’Fathartaigh MS, Peisach AR, et al. Epinephrine as an inotropic agent in septic shock: a dose-profile analysis. Crit Care Med 1993; 21: 70–7
Marik P. Aminoglycoside volume of distribution and illness severity in critically ill septic patients. Anesth Intensive Care 1993; 21: 172–3
Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818–29
Knaus WA, Zimmerman JE, Wagner DP, et al. APACHE-acute physiology and chronic health evaluation: a physiologically based classification system. Crit Care Med 1981; 9: 591–7
Knaus WA, Wagner DP, Draper EA, et al. The APACHE III prognostic system: risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991; 100: 1619–36
Le Gall JR, Loirat P, Alperovitch A, et al. A simplified acute score for ICU patients. Crit Care Med 1984; 12: 975–9
Le Gall JR, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS-II) based on an European North American multicenter study. JAMA 1993; 270: 2957–63
Lemeshow S, Teres D, Klar J, et al. Mortality probability models (MPM II) based on an international cohort of intensive care unit patients. JAMA 1993; 270: 2478–86
Rowan KM, Kerr JH, Major E, et al. APACHE II study in Britain and Ireland-II: outcome comparisons of intensive care after adjustment for case mix by the American APACHE II method. BMJ 1993; 307: 977–81
Zimmerman JE, Knaus WA, Judson JA, et al. Patients selection for intensive care: a comparison of New Zealand and United States hospitals. Crit Care Med 1988; 16: 318–26
Sirio CA, Tajimi K, Tase C, et al. An initial comparison of intensive care in Japan and United States. Crit Care Med 1992; 20: 1207–15
Nicolas F, Le Gall JR, Alperovitch A, et al. Influence of patients’ age on survival, level of therapy and length of stay in intensive care units. Intensive Care Med 1987; 13: 9–13
Tran DD, Groeneveld AB, Meulen J, et al. Age, chronic disease, sepsis, organ system failure, and mortality in a medical intensive care unit. Crit Care Med 1990; 18: 474–9
Niskanen M, Kari A, Nikki P, et al. Prediction of outcome from intensive care after gastroenterologic emergency. Acta Anaesthesiol Scand. In press
Niskanen M, Kari A, Nikki P, et al. Acute Physiology and Chronic Health Evaluation (APACHE) II and Glasgow Coma scores as predictors of outcome after cardiac arrest. Crit Care Med 1991; 19: 1465–73
Intensive care for the elderly [editorial]. Lancet 1991; 337: 209–10
Smythe MA, Melendy S, Jahns B, et al. An exploratory analysis of medication utilization in a medical intensive care unit. Crit Care Med 1993; 21: 1319–23
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Niskanen, M., Niskanen, L. Is the Acute Physiology and Chronic Health Evaluation (APACHE) Scale Agist?. Drugs & Aging 5, 153–155 (1994). https://doi.org/10.2165/00002512-199405030-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002512-199405030-00001